Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions

American Journal of Reproductive Immunology

Volumn 49, Issue 1, 2003, Pages 21-29

  Graphou, Olga ^b   Chioti, Athanasia ^a   Pantazi, Ageliki ^b   Tsekoura, Christina ^a   Kontopoulou, Virginia ^a   Georgiadou, Eleftheria ^a   Balafoutas, Christos ^a   Koussoulakos, Stavros ^b   Margaritis, Loukas H ^a   Varla Leftherioti, Marighoula ^b  

^a HELENA VENIZELOU HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Intravenous immunoglobulin; Recurrent spontaneous abortions; Th1 Th2 balance

Indexed keywords

CELL SURFACE MARKER; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY;

ALLOIMMUNE DISEASE; ALLOIMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; POLARIZATION; PRIORITY JOURNAL; RECURRENT DISEASE; SPONTANEOUS ABORTION; TH1 CELL; TH2 CELL;

ABORTION, HABITUAL; ADJUVANTS, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; TH1 CELLS; TH2 CELLS;

EID: 10744220585     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2003.01169.x     Document Type: Article

References (47)

1. The German RSA/IVIG Group. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994; 101:1072-1077.
2. Coulam CB, Krysa L, Stern JJ, Bastillo M: Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34:333-337.
3. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N: Placebo-controlled trial in treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortion with Iv immunoglobulin. Hum Reprod 1995; 10:2690-2695.
4. Stephenson MD, Drener K, Houlihan E, Wu V: Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin. A prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998; 39:82-88.
5. Carp HJA, Toder E, Gazit E, Ahiron R, Torchinski A, Mashiach S, Shoenfeld Y: Further experience with intravenous immunoglobulin in women with recurrent miscarriages and a poor prognosis. Am J Reprod Immunol 2001; 46:267-273.
6. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
7. Orvieto R, Achiron A, Ben-Rafael Z, Achiron R: Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril 1991; 56:1013-1018.
8. Daya S, Gunby J, Clark DA: Intravenous immunoglobulin therapy for recurrent spontaneous abortion: A meta-analysis. Am J Reprod Immunol 1998; 39:69-76.
9. Stern JJ, Coulam CB: Current status of immunologic recurrent pregnancy loss. Curr Opin Obstet Gynaecol 1993; 5:252-259.
10. Branch DW: Antiphospholipid antibodies and reproductive outcome: The current state of affairs. J Reprod Immunol 1998; 38:75-87.
11. Kutteh WH, Rote NS, Silver R: Antiphospholipid antibodies and reproduction: The antiphospholipid antibody syndrome. Am J Reprod Immunol 1999; 41:133-152.
12. McIntyre JA, Coulam CB, Faulk WP: Recurrent spontaneous abortion. Am J Reprod Immunol 1989;21:100-104.
13. Voisin G-A, Raghupathy R: Immunodeviation of the immune response during pregnancy. In Immunology of Human Reproduction, M Kupisz, N Fernandez (eds). BIOS Scientific Publishers Limited, Oxford, 1995, pp. 335-353.
14. Wegmann TG, Lin H, Guilbert L, Mosmann T: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
15. Raghupathy R: TH1-Type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
16. Kiprov DD, Nachtigall R, Weaver RC, Jacobson A, Main E, Garovoy M: The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 1996; 36:228-234.
17. Redline RW, Zaragoza M, Hassold T: Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions. Hum Pathol 1999; 30(1):93-100.
18. Kwak JY, Beer AE, Kim SH, Mantouvalos HP: Immunopathology of the implantation site utilizing monoclonal antibodies to natural killer cells in women with recurrent pregnancy losses. Am J Reprod Immunol 1999; 41:91-98.
19. Salafia CM, Cowchock FS: Placental pathology and antiphospholipid antibodies: A descriptive study. Am J Perinatol 1997; 14:435-441.
20. Schauer U, Jung T, Krug N, Frew A: Measurement of intracellular cytokines. Immunol Today 1996; 17:305-306.
21. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 7:138-146.
22. Carreras LH, Perez GN, Vega HR, Maclouf J: Lupus anticoagulant and recurrent fetal loss: Successful treatment with gammaglobulin. Lancet 1988; 2:393.
23. Mueller-Eckhardt G, Heine O, Neppert J, Kunzel W, Mueller-Eckhardt C: Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. Vox Sang 1989; 56:151-154.
24. Kimberly RP, Salmon JE, Russel JB: Modulation of mononuclear phagocyte function by intravenous gammaglobulin. J Immunol 1987; 132:745-750.
25. Rossi F, Dietrich G, Kazatchkine MD: Anti idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol Rev 1989; 110:135-149.
26. Klaesson S, Ringden O, Markling L, Remberger M, Lundkvist I: Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro. Scand J Immunol 1993; 38:477-484.
27. Kondo N, Ozawa T, Mushiake K, Motoyoshi F, Kameyama T, Kasahara K, Kaneko H, Yamashina M, Kato Y, Oni T: Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J Clin Immunol 1991; 11:152-158.
28. Kulics J, Rajnavolge E, Fust G, Gergely J: Interaction of C3 and C3b with immunoglobulin. J Mol Immunol 1983; 20:805-810.
29. Anderson JP, Anderson UG: Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 1990; 71:372-376.
30. Caccavo D, Vaccaro F, Ferri GM, Amoroso A, Bonorno L: Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. J Autoimmunol 1994; 7:537-548.
31. Lee L, Whitsett CF, McNicholl JM, Hodge TW, Hooper J: Immunologically active proteins in intravenous immunoglobulin. Lancet 1992; 342:678.
32. Maruyama T, Tsunehisa M, Iwasaki K, Sugi T, Saito S, Umeuchi M, Ozawa N, Matsubayashi H, Nozawa S: The influence of intravenous immunoglobulin treatment on maternal immunity in women with unexplained recurrent miscarriage. Am J Reprod Immunol 1994; 31(1):7-18.
33. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Intravenous immunoglobulin inhibits Natural Killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:370-375.
34. Morikawa M, Yamada H, Kato EH, Shigeki S, Kishida T, Yamada T, Kobashi G, Fujimoto S: Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: Down-regulation of NK cell activity and subsets. Am J Reprod Immunol 2001; 46:399-404.
35. Szereday L, Spath P, Szekeres-Bartho J: Natural Killer cell activity and cytokine production after in vitro immunoglobulin treatment of lymphocytes derived from pregnant women with or without risk for spontaneous abortion. Am J Reprod Immunol 1999; 42:282-287.
36. Chaouat G, Meliani A, Martal J, Raghupathy R, Elliot J, Mosmann T, Wegmann T: IL-10 prevents naturally occurring fetal loss in the CBA-DBA/2 mating combination and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-Tau. J Immunol 1995; 154:4261-4268.
37. Hayakawa S, Karasaki Suzuki M, Itoh T, Ishii M, Kaneada T, Nagai N, Takahashi Yamamoto N, Tochigi M, Chishima F, Fujii TK, Oyama J, Kitanaka S, Satoh K: Effects of paternal lymphocyte immunization on peripheral TH1/TH2 balance and TCR Vβ and Vγ repertoire usage of patients with recurrent spontaneous abortions. Am J Reprod Immunol 2000; 43:107-115.
38. Maino VC, Picker LJ: Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression. Cytometry 1998; 5:207-215.
39. Toungouz M, Denys C, Dupont E: Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins. Transplantation 1996; 62:1292-1296.
40. Bakimer R, Guilburd B, Zurgil N, Shoenfield Y: The effect of intravenous γ-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 1993; 69:97-102.
41. Krause I, Blank M, Levi Y, Koike T, Barak V, Shoenfeld Y: Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol 1999; 111(1):190-197.
42. Fujii T, Hamai Y, Kozuma S, Miki A, Yamashita T, Hvodo H, Unno N, Taketani Y: Effects of sairei-to and tokishakuyaku-san on cytokine release from peripheral blood mononuclear cells upon recognition of HLA-G protein in the treatment of recurrent abortion. Methods Find Exp Clin Pharmacol 1999; 21:261-264.
43. Van Schaik IN, Vermeulen M, Brand A. Immunomodulation and remyelination: Two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies? Mult Scler 1997; 3:98-104.
44. Campbell DE, Georgiou GM, Kemp AS: Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with staphylococcal superantigen. Cytokine 1999; 11:359-365.
45. Rabinovich N, Gelfand EW, Leung DY: The role of immunoglobulin therapy in allergic diseases. Allergy 1999; 54:662-668.
46. Huang JL, Lee WY, Chen LC, Kuo ML, Hsieh KH: Changes in the serum levels of interleukin-2, intracellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol 2000; 84:345-352.
47. Grewe M, Bruijnzeel-Koomen C, Schopf E, Thepen T, Langeveld-Wildschut A, Ruzicka T, Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19:359-361.